Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes (CAAD-PVC): A Randomised Controlled Trial

NCT07445334 is registered in ClinicalTrials.gov with Western Sydney Local Health District as lead sponsor.

NCT NCT07445334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07445334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes (CAAD-PVC): A Randomised Controlled Trial
Lead sponsor
Western Sydney Local Health District
Phase
Not applicable
Overall status
Recruiting
Start date
March 31, 2026
Completion date
March 1, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature ventricular beats, premature ventricular complexes, premature ventricular contraction (pvc)